Accessibility links
Minn. Pension Fund Seeks Pfizer Price Drop Managers of Minnesota's $43-billion pension fund propose a shareholder resolution that would require drug giant Pfizer to lower prescription drug prices in the United States. Critics say the effort could backfire, harming Pfizer's stock price and lowering the value of the state's retiree pension fund. Minnesota Public Radio's Tom Scheck reports.

Business

Minn. Pension Fund Seeks Pfizer Price Drop

Heard on Morning Edition

Minn. Pension Fund Seeks Pfizer Price Drop

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/1778056/1778057" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Managers of Minnesota's $43-billion pension fund propose a shareholder resolution that would require drug giant Pfizer to lower prescription drug prices in the United States. Critics say the effort could backfire, harming Pfizer's stock price and lowering the value of the state's retiree pension fund. Minnesota Public Radio's Tom Scheck reports.